These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 34378854)

  • 1. Assessment of clinical data on urocortins and their therapeutic potential in cardiovascular diseases: A systematic review and meta-analysis.
    Kovács DK; Farkas N; Soós A; Hegyi P; Kelava L; Eitmann S; Schekk A; Molnár Z; Erőss B; Balaskó M
    Clin Transl Sci; 2021 Nov; 14(6):2461-2473. PubMed ID: 34378854
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiovascular effects of urocortin 2 and urocortin 3 in patients with chronic heart failure.
    Stirrat CG; Venkatasubramanian S; Pawade T; Mitchell AJ; Shah AS; Lang NN; Newby DE
    Br J Clin Pharmacol; 2016 Oct; 82(4):974-82. PubMed ID: 27275843
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immediate and sustained blood pressure lowering by urocortin 2: a novel approach to antihypertensive therapy?
    Dieterle T; Meili-Butz S; Bühler K; Morandi C; John D; Buser PT; Rivier J; Vale WW; Peterson KL; Brink M
    Hypertension; 2009 Apr; 53(4):739-44. PubMed ID: 19204182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiovascular Effects of Urocortin-2: Pathophysiological Mechanisms and Therapeutic Potential.
    Monteiro-Pinto C; Adão R; Leite-Moreira AF; Brás-Silva C
    Cardiovasc Drugs Ther; 2019 Oct; 33(5):599-613. PubMed ID: 31512017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beneficial hemodynamic, endocrine, and renal effects of urocortin in experimental heart failure: comparison with normal sheep.
    Rademaker MT; Charles CJ; Espiner EA; Fisher S; Frampton CM; Kirkpatrick CM; Lainchbury JG; Nicholls MG; Richards AM; Vale WW
    J Am Coll Cardiol; 2002 Oct; 40(8):1495-505. PubMed ID: 12392842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vascular effects of urocortins 2 and 3 in healthy volunteers.
    Venkatasubramanian S; Griffiths ME; McLean SG; Miller MR; Luo R; Lang NN; Newby DE
    J Am Heart Assoc; 2013 Jan; 2(1):e004267. PubMed ID: 23525432
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urocortin 2 infusion in healthy humans: hemodynamic, neurohormonal, and renal responses.
    Davis ME; Pemberton CJ; Yandle TG; Fisher SF; Lainchbury JG; Frampton CM; Rademaker MT; Richards AM
    J Am Coll Cardiol; 2007 Jan; 49(4):461-71. PubMed ID: 17258092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distribution of urocortins and corticotropin-releasing factor receptors in the cardiovascular system.
    Takahashi K
    Int J Endocrinol; 2012; 2012():395284. PubMed ID: 22675352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Urocortin: molecular biology and cardiovascular effects].
    Raddino R; Pedrinazzi C; Zanini G; Robba D; Bonadei I; Scarabelli TM; Cas LD
    G Ital Cardiol (Rome); 2007 Apr; 8(4):236-45. PubMed ID: 17506295
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endogenous urocortins reduce vascular tone and renin-aldosterone/endothelin activity in experimental heart failure.
    Rademaker MT; Charles CJ; Espiner EA; Frampton CM; Lainchbury JG; Richards AM
    Eur Heart J; 2005 Oct; 26(19):2046-54. PubMed ID: 15821006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urocortin 3: haemodynamic, hormonal, and renal effects in experimental heart failure.
    Rademaker MT; Cameron VA; Charles CJ; Richards AM
    Eur Heart J; 2006 Sep; 27(17):2088-98. PubMed ID: 16825287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urocortin-2 infusion in acute decompensated heart failure: findings from the UNICORN study (urocortin-2 in the treatment of acute heart failure as an adjunct over conventional therapy).
    Chan WY; Frampton CM; Crozier IG; Troughton RW; Richards AM
    JACC Heart Fail; 2013 Oct; 1(5):433-41. PubMed ID: 24621976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrated hemodynamic, hormonal, and renal actions of urocortin 2 in normal and paced sheep: beneficial effects in heart failure.
    Rademaker MT; Cameron VA; Charles CJ; Richards AM
    Circulation; 2005 Dec; 112(23):3624-32. PubMed ID: 16330704
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of urocortin 1 infusion in humans with stable congestive cardiac failure.
    Davis ME; Pemberton CJ; Yandle TG; Lainchbury JG; Rademaker MT; Nicholls MG; Frampton CM; Richards AM
    Clin Sci (Lond); 2005 Oct; 109(4):381-8. PubMed ID: 15882144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urocortin Role in Ischemia Cardioprotection and the Adverse Cardiac Remodeling.
    Calderón-Sánchez EM; Falcón D; Martín-Bórnez M; Ordoñez A; Smani T
    Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34829997
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urocortin 3 Gene Transfer Increases Function of the Failing Murine Heart.
    Giamouridis D; Gao MH; Lai NC; Tan Z; Kim YC; Guo T; Miyanohara A; Blankesteijn MW; Biessen EAL; Hammond HK
    Hum Gene Ther; 2019 Jan; 30(1):10-20. PubMed ID: 30003813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The powerful cardioprotective effects of urocortin and the corticotropin releasing hormone (CRH) family.
    Davidson SM; Rybka AE; Townsend PA
    Biochem Pharmacol; 2009 Jan; 77(2):141-50. PubMed ID: 18817752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urocortins: take them to heart.
    Scarabelli T; Knight R
    Curr Med Chem Cardiovasc Hematol Agents; 2004 Oct; 2(4):335-342. PubMed ID: 15320777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardioprotective Utility of Urocortin in Myocardial Ischemia- Reperfusion Injury: Where do We Stand?
    Basman C; Agrawal P; Knight R; Saravolatz L; McRee C; Chen-Scarabelli C; Narula J; Scarabelli T
    Curr Mol Pharmacol; 2018; 11(1):32-38. PubMed ID: 28228090
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urocortin 1 administration from onset of rapid left ventricular pacing represses progression to overt heart failure.
    Rademaker MT; Charles CJ; Richards AM
    Am J Physiol Heart Circ Physiol; 2007 Sep; 293(3):H1536-44. PubMed ID: 17526650
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.